1887
  1. Home
  2. Eurosurveillance
  3. Volume 27, Issue 24, 16/Jun/2022
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

We describe a gonorrhoea case with ceftriaxone plus high-level azithromycin resistance. In April 2022, an Austrian heterosexual male was diagnosed with gonorrhoea after sexual intercourse with a female sex worker in Cambodia. Recommended treatment with ceftriaxone (1 g) plus azithromycin (1.5 g) possibly failed. Worryingly, this is the second strain in an Asian genomic sublineage including high-level azithromycin-resistant strains that developed ceftriaxone resistance by acquisition of mosaic -60.001. Enhanced resistance surveillance and actions are imperative to prevent spread.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.24.2200455
2022-06-16
2024-12-30
/content/10.2807/1560-7917.ES.2022.27.24.2200455
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/24/eurosurv-27-24-3.html?itemId=/content/10.2807/1560-7917.ES.2022.27.24.2200455&mimeType=html&fmt=ahah

References

  1. Unemo M, Ross J, Serwin AB, Gomberg M, Cusini M, Jensen JS. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2020;956462420949126.  https://doi.org/10.1177/0956462420949126  PMID: 33121366 
  2. St Cyr S, Barbee L, Workowski KA, Bachmann LH, Pham C, Schlanger K, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1911-6.  https://doi.org/10.15585/mmwr.mm6950a6  PMID: 33332296 
  3. World Health Organization (WHO). WHO guidelines for the treatment of Neisseria gonorrhoeae. Geneva: WHO; 2016. Available from: https://www.who.int/publications/i/item/9789241549691
  4. Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7(7):821-34.  https://doi.org/10.1586/eri.09.63  PMID: 19735224 
  5. Cole MJ, Day M, Jacobsson S, Amato-Gauci AJ, Spiteri G, Unemo M, the European Gonorrhoea Response Plan Group, European Gonorrhoea Response Plan Group. The European response to control and manage multi- and extensively drug-resistant Neisseria gonorrhoeae. Euro Surveill. 2022;27(18).  https://doi.org/10.2807/1560-7917.ES.2022.27.18.2100611  PMID: 35514307 
  6. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters; version 12.0, 1 Jan 2022. EUCAST; 2022. Available from: https://www.eucast.org/clinical_breakpoints
  7. Eyre DW, Sanderson ND, Lord E, Regisford-Reimmer N, Chau K, Barker L, et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018;23(27):1800323.  https://doi.org/10.2807/1560-7917.ES.2018.23.27.1800323  PMID: 29991383 
  8. Jennison AV, Whiley D, Lahra MM, Graham RM, Cole MJ, Hughes G, et al. Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018. Euro Surveill. 2019;24(8):1900118.  https://doi.org/10.2807/1560-7917.ES.2019.24.8.1900118  PMID: 30808445 
  9. Sánchez-Busó L, Yeats CA, Taylor B, Goater RJ, Underwood A, Abudahab K, et al. A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch. Genome Med. 2021;13(1):61.  https://doi.org/10.1186/s13073-021-00858-2  PMID: 33875000 
  10. Unemo M, Seifert HS, Hook EW 3rd, Hawkes S, Ndowa F, Dillon JR. Gonorrhoea. Nat Rev Dis Primers. 2019;5(1):79.  https://doi.org/10.1038/s41572-019-0128-6  PMID: 31754194 
  11. Golparian D, Harris SR, Sánchez-Busó L, Hoffmann S, Shafer WM, Bentley SD, et al. Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928-2013): antimicrobial use/misuse selects for resistance and drives evolution. BMC Genomics. 2020;21(1):116.  https://doi.org/10.1186/s12864-020-6511-6  PMID: 32013864 
  12. Golparian D, Kittiyaowamarn R, Paopang P, Sangprasert P, Sirivongrangson P, Franceschi F, et al. Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018. J Antimicrob Chemother. 2022;dkac158.  https://doi.org/10.1093/jac/dkac158  PMID: 35542983 
  13. Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M. New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016;60(7):4339-41.  https://doi.org/10.1128/AAC.00504-16  PMID: 27067334 
  14. Lahra MM, Martin I, Demczuk W, Jennison AV, Lee KI, Nakayama SI, et al. Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerg Infect Dis. 2018;24(4):735-40.  https://doi.org/10.3201/eid2404.171873  PMID: 29553335 
  15. Poncin T, Fouere S, Braille A, Camelena F, Agsous M, Bebear C, et al. Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. Euro Surveill. 2018;23(21):1800264.  https://doi.org/10.2807/1560-7917.ES.2018.23.21.1800264  PMID: 29845928 
  16. Lee K, Nakayama SI, Osawa K, Yoshida H, Arakawa S, Furubayashi KI, et al. Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates. J Antimicrob Chemother. 2019;74(7):1812-9.  https://doi.org/10.1093/jac/dkz129  PMID: 31002306 
  17. Chen SC, Yuan LF, Zhu XY, van der Veen S, Yin YP. Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. J Antimicrob Chemother. 2020;75(9):2499-502.  https://doi.org/10.1093/jac/dkaa196  PMID: 32473014 
  18. Golparian D, Rose L, Lynam A, Mohamed A, Bercot B, Ohnishi M, et al. Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Euro Surveill. 2018;23(47):1800617.  https://doi.org/10.2807/1560-7917.ES.2018.23.47.1800617  PMID: 30482267 
  19. Sánchez-Busó L, Cole MJ, Spiteri G, Day M, Jacobsson S, Golparian D, et al. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. Lancet Microbe. 2022;3(6):e452-63.  https://doi.org/10.1016/S2666-5247(22)00044-1  PMID: 35659907 
  20. Unemo M, Golparian D, Sánchez-Busó L, Grad Y, Jacobsson S, Ohnishi M, et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother. 2016;71(11):3096-108.  https://doi.org/10.1093/jac/dkw288  PMID: 27432602 
  21. Poncin T, Merimeche M, Braille A, Mainardis M, Bebear C, Jacquier H, et al. Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-eastern Asia, France, June 2019. Euro Surveill. 2019;24(36):1900528.  https://doi.org/10.2807/1560-7917.ES.2019.24.36.1900528  PMID: 31507264 
  22. Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P, et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. Lancet Microbe. 2021;2(11):e627-36.  https://doi.org/10.1016/S2666-5247(21)00171-3  PMID: 35544082 
  23. Day MJ, Jacobsson S, Spiteri G, Kulishev C, Sajedi N, Woodford N, et al. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. BMC Infect Dis. 2022;22(1):524.  https://doi.org/10.1186/s12879-022-07509-w  PMID: 35672671 
Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Sonja+Pleininger&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pleininger Sonja</a>, <a href="/search?value1=Alexander+Indra&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Indra Alexander</a>, <a href="/search?value1=Daniel+Golparian&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Golparian Daniel</a>, <a href="/search?value1=Florian+Heger&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Heger Florian</a>, <a href="/search?value1=Stefanie+Schindler&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Schindler Stefanie</a>, <a href="/search?value1=Susanne+Jacobsson&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Jacobsson Susanne</a>, <a href="/search?value1=Stefan+Heidler&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Heidler Stefan</a>, <a href="/search?value1=Magnus+Unemo&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Unemo Magnus</a></span>. Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022. <a href="/content/ecdc">Euro Surveill.</a> 2022;27(24):pii=2200455. <a href="https://doi.org/10.2807/1560-7917.ES.2022.27.24.2200455" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2022.27.24.2200455</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 07 Jun 2022;&nbsp;&nbsp; <span class="generated">Accepted</span>: 14 Jun 2022 </span> </p>
/content/10.2807/1560-7917.ES.2022.27.24.2200455
/content/10.2807/1560-7917.ES.2022.27.24.2200455
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error